Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human Oncostatin M (HEK-293-expressed)
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 8475OM010/CF
This item is not returnable.
View return policy
Description
The Recombinant Human Oncostatin M (HEK-293-expressed) is derived from HEK293. The Recombinant Human Oncostatin M (HEK-293-expressed) has been validated for the following applications: Bioactivity.Specifications
P13725 | |
5008 | |
10μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
MGC20461, oncostatin M, oncostatin-M | |
OSM | |
Unconjugated | |
Recombinant | |
>95%, by SDS-PAGE with Silver Staining |
Bioactivity | |
Observed M.W.: 27-35kDa, reducing conditions, Theoretical M.W.: 22kDa | |
Human embryonic kidney cell,HEK293-derived human Oncostatin M/OSM protein Ala26-Arg221 | |
<0.10 EU per 1μg of the protein by the LAL method. | |
Oncostatin M/OSM | |
Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED50 for this effect is typically 0.05-0.3ng/mL. | |
Human | |
Human embryonic kidney cell, HEK293-derived Ala26-Arg221 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction